You are here

Article info

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma

Authors

  • Qi Liu State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China University of the Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Ye Tian State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yanyan Li State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China PubMed articlesGoogle scholar articles
  • Wei Zhang Hefei Institute of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Wenxuan Cai State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yaju Liu Hefei Institute of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Yuefei Ren State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Zhaoduan Liang State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China PubMed articlesGoogle scholar articles
  • Peipei Zhou State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Yajing Zhang State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China University of the Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Yifeng Bao State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yi Li State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China University of the Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles

Citation

Liu Q, Tian Y, Li Y, et al
In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer 2020;8:e001748. doi: 10.1136/jitc-2020-001748
Online issue publication 
December 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.